Harmony Biosciences Management
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Harmony Biosciences Management sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Harmony Biosciences Management: 10 sponsored US clinical trials, 4 recruiting.
Harmony Biosciences Management sponsors 10 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prader-Willi Syndrome, with 2 trials.
Top-decile sponsor footprint
Harmony Biosciences Management ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
NCT07675135
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
NCT07500090
A Study of Pitolisant in Patients With Prader-Willi Syndrome
NCT06366464
WAKIX® (Pitolisant) Pregnancy Registry
NCT05536011
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
NCT04257929
A Study of HBS-201 (Pitolisant Delayed-release)
NCT07051252
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
NCT05458128
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
NCT05156047
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
NCT04886518
Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
NCT05149898
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 5 |
Therapeutic Areas
What is open in the Harmony Biosciences Management pipeline
4 recruiting of 10 indexed (40% open); 5 completed (50%).
Phase mix: 5 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Prader-Willi Syndrome (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Harmony Biosciences Management: open-pipeline peers nationwide
Peers matched on 10 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Harmony Biosciences Management sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Harmony Biosciences Management page
10 registered trials is a research-attention snapshot, not an endorsement of Harmony Biosciences Management or any single study.
- 4 of Harmony Biosciences Management's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prader-Willi Syndrome is the condition Harmony Biosciences Management studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prader-Willi Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Harmony Biosciences Management pipeline card: 10 registered trials from official public datasets.Report a data error.